Biomedit
An innovation company that discovers, designs, and develops novel probiotics, microbiome derived bioactives, & engineered microbial medicines to address unmet needs in animal health.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD247—371m (Dealroom.co estimates Apr 2022.)
Fishers Indiana (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | $40.0m | Series A | |
* | N/A | Early VC | |
* | $4.5m | Grant | |
| Total Funding | AUD68.8m | ||